The patient- derived cancer spheroid model predicts response to chemotherapy in curatively resected patients with high-risk stage II and stage III colon cancer

被引：0
|
作者：
Mayer, Barbara [1 ]
Held, Isabella [1 ]
Halfter, Kathrin [2 ]
Werner, Jens [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Gen Visceral & Transplantat Surg, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [2] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [3] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Kosuke Mima
    Nobutomo Miyanari
    Keisuke Kosumi
    Takuya Tajiri
    Kosuke Kanemitsu
    Toru Takematsu
    Mitsuhiro Inoue
    Takao Mizumoto
    Tatsuo Kubota
    Hideo Baba
    International Journal of Clinical Oncology, 2021, 26 : 903 - 912
  • [4] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Mima, Kosuke
    Miyanari, Nobutomo
    Kosumi, Keisuke
    Tajiri, Takuya
    Kanemitsu, Kosuke
    Takematsu, Toru
    Inoue, Mitsuhiro
    Mizumoto, Takao
    Kubota, Tatsuo
    Baba, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 903 - 912
  • [5] Microsatellite Status Predicts Effectiveness of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
    Krishnamurty, Devi Mukkai
    Park, Yu-Soon A.
    Tashjian, Nara
    Aurit, Sarah J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S65 - S66
  • [6] The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
    Hsieh, Mei-Chin
    Thompson, Trevor
    Wu, Xiao-Cheng
    Styles, Timothy
    O'Flarity, Mary B.
    Morris, Cyllene R.
    Chen, Vivien W.
    CANCER MEDICINE, 2016, 5 (05): : 871 - 880
  • [7] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [8] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [9] IDENTIFICATION OF HIGH-RISK PATIENTS IN STAGE II COLON CANCER
    Lanza, Giovanni
    Gafa, Roberta
    Santini, Alessandra
    Maestri, Iva
    Guerzoni, Laura
    Liboni, Alberto
    Azzena, Gianfranco
    Lelli, Giorgio
    Cavazzini, Luigi
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [10] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    LANCET ONCOLOGY, 2013, 14 (13): : 1247 - 1248
12345